Date updated:04-22-2009
With Big Pharma tightening the belt, is the group cheap? Or will unknowns of healthcare reform keep a lid on stock prices?

-
TEVA
Teva Pharmaceutic - $53.43
- +1.35%
- $53.02
I’m concerned about all the variables in this space, explains Pete Najarian. But the name to watch is probably Teva (TEVA). They’re heavily involved in generic drugs and the environment should be good for generics.

-
GSK
Glaxosmithkline P - $42.14
- +1.47%
- $42.47
Najarian also liked GlaxoSmithKline(GSK) for going out and buying closely held Stiefel Laboratories for $3.4 billion, including debt.

-
AMLN
Amylin Pharmaceut - $12.47
- +0.24%
- $12.51
Also I’m keeping an eye on Amylin (AMLN). - Pete Najarian

-
ABT
Abbott Laboratori - $53.13
- -0.95%
- $53.72
I think the trade is long Abbott Labs (ABT), adds Guy Adami.

-
PPH
Ml Pharma Holdr12 - $65.34
- +0.54%
- $65.19
My trade is the Pharmaceutical HOLDRs (PPH), adds Karen Finerman. I think the valuations are compelling.

-
AMGN
Amgen Inc. - $56.25
- +1.57%
- $55.79
I’d look at Amgen (AMGN), adds Joe Terranova. I just got stopped out of my trade but I think it’s the bottom.
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Top 5 Small-Cap Stocks: N...
- » Echo5Joker's Portfolio
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Nov. 24, 2009 Don’t dismiss dividends right now. While stocks may have made significant strides in the rally that’s taken hold of the m...
By Roberto Pedone Posted on Nov. 24, 2009 10 Terrific Dividend Stocks: This Barron’s article highlights 10 high-quality dividend-paying stocks for investors who’re ...
By Jonas Elmerraji Posted on Nov. 23, 2009 As well as broad-based indexes have performed in the last few months, Stockpickr's weekly Rocket Stocks list has managed to d...
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
A. From what I understand, more reporting
requirements, more strenuous audits and
more penalties for financial firms. Lots
of other related regulations are being
proposed including compensation
reporting by top bank executives and
hedge fund registrations.
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some stocks that moved up on unusual volume on Nov. 23, 2009. more
These are the stocks from Jim Cramer's Nov. 23 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more
Here are some of the biggest stocks that made the 52-week high list on Nov. 24, 2009. more











Comments not available